Immix Biopharma, Inc.

NasdaqCM:IMMX Stock Report

Market Cap: US$47.3m

Immix Biopharma Management

Management criteria checks 3/4

Immix Biopharma's CEO is Ilya Rachman, appointed in Jan 2012, has a tenure of 12.83 years. total yearly compensation is $1.13M, comprised of 39.5% salary and 60.5% bonuses, including company stock and options. directly owns 4.13% of the company’s shares, worth $1.95M. The average tenure of the management team and the board of directors is 3.7 years and 3.5 years respectively.

Key information

Ilya Rachman

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage39.5%
CEO tenure12.8yrs
CEO ownership4.1%
Management average tenure3.7yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Deliver On Growth Plans?

Nov 11
Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Deliver On Growth Plans?

Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?

Aug 12
Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?

Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?

Nov 28
Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?

Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth?

Jul 12
Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth?

We're Not Very Worried About Immix Biopharma's (NASDAQ:IMMX) Cash Burn Rate

Mar 29
We're Not Very Worried About Immix Biopharma's (NASDAQ:IMMX) Cash Burn Rate

Immix Biopharma (NASDAQ:IMMX) Is In A Good Position To Deliver On Growth Plans

Sep 13
Immix Biopharma (NASDAQ:IMMX) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Immix Biopharma (NASDAQ:IMMX) Will Use Its Cash Wisely

May 21
We're Hopeful That Immix Biopharma (NASDAQ:IMMX) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Ilya Rachman's remuneration changed compared to Immix Biopharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$22m

Jun 30 2024n/an/a

-US$19m

Mar 31 2024n/an/a

-US$18m

Dec 31 2023US$1mUS$446k

-US$15m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$11m

Mar 31 2023n/an/a

-US$9m

Dec 31 2022US$2mUS$425k

-US$8m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$26m

Mar 31 2022n/an/a

-US$25m

Dec 31 2021US$397kUS$193k

-US$24m

Compensation vs Market: Ilya's total compensation ($USD1.13M) is above average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Ilya's compensation has been consistent with company performance over the past year.

CEO

Ilya Rachman (51 yo)

12.8yrs

Tenure

US$1,129,881

Compensation

Dr. Ilya Rachman, MD, PhD, MBA, Co-Founder, Chairman and Chief Executive Officer at Immix Biopharma, Inc since 2012. Dr. Rachman is a pioneering physician/scientist, cell biologist and among the first to f...

Leadership Team

NamePositionTenureCompensationOwnership
Ilya Rachman
Co-Founder12.8yrsUS$1.13m4.13%
$ 2.0m
Gabriel Morris
CFO & Director3.7yrsUS$1.13m1.04%
$ 491.6k
Graham Ross
Chief Medical Officer & Head of Clinical Development3.4yrsUS$104.42k0%
$ 0
Sean Senn
Co-Founderno datano data3.27%
$ 1.5m
Vladimir Torchilin
Scientific Co-Founder12.8yrsno data3.29%
$ 1.6m
Nandan Oza
Head of Chemistry7.5yrsno datano data
David Marks
Chief Medical Officer of Cell Therapy1.8yrsno datano data
Gerhard Bauer
Head of Cell Therapy Manufacturing1.8yrsno datano data

3.7yrs

Average Tenure

62yo

Average Age

Experienced Management: IMMX's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ilya Rachman
Co-Founder12.8yrsUS$1.13m4.13%
$ 2.0m
Gabriel Morris
CFO & Director3.7yrsUS$1.13m1.04%
$ 491.6k
Jane Buchan
Independent Director3.4yrsUS$173.63k0.082%
$ 38.6k
George Sledge
Member of Scientific Advisory Boardno datano datano data
Gary Schiller
Member of Scientific Advisory Boardno datano datano data
Larry Norton
Chair of Scientific Advisory Boardno datano datano data
Jason Hsu
Independent Director11.8yrsUS$156.38k3.25%
$ 1.5m
Magda Marquet
Independent Director3.4yrsUS$180.64k0.17%
$ 79.3k
Helen Adams
Lead Independent Director3.4yrsUS$429.37k0.64%
$ 300.6k
Carey Ng
Independent Director5yrsUS$159.88k0.073%
$ 34.4k
Razelle Kurzrock
Member of Scientific Advisory Boardno datano datano data
Galit Lahav
Member of Scientific Advisory Board3.3yrsno datano data

3.5yrs

Average Tenure

60yo

Average Age

Experienced Board: IMMX's board of directors are considered experienced (3.5 years average tenure).